These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19476747)

  • 1. Thoracic aortic dissection: are matrix metalloproteinases involved?
    Zhang X; Shen YH; LeMaire SA
    Vascular; 2009; 17(3):147-57. PubMed ID: 19476747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase levels in chronic thoracic aortic dissection.
    Zhang X; Wu D; Choi JC; Minard CG; Hou X; Coselli JS; Shen YH; LeMaire SA
    J Surg Res; 2014 Jun; 189(2):348-58. PubMed ID: 24746253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors.
    Lesauskaite V; Tanganelli P; Sassi C; Neri E; Diciolla F; Ivanoviene L; Epistolato MC; Lalinga AV; Alessandrini C; Spina D
    Hum Pathol; 2001 Sep; 32(9):1003-11. PubMed ID: 11567232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of metalloproteinases-9 and -2 in the acute and subacute phases of type A and type B aortic dissection.
    Sangiorgi G; Trimarchi S; Mauriello A; Righini P; Bossone E; Suzuki T; Rampoldi V; Eagle KA
    J Cardiovasc Med (Hagerstown); 2006 May; 7(5):307-15. PubMed ID: 16645407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections.
    Koullias GJ; Ravichandran P; Korkolis DP; Rimm DL; Elefteriades JA
    Ann Thorac Surg; 2004 Dec; 78(6):2106-10; discussion 2110-1. PubMed ID: 15561045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects].
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Ann Biol Clin (Paris); 2003; 61(2):147-58. PubMed ID: 12702469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stanford-A acute aortic dissection, inflammation, and metalloproteinases: a review.
    Cifani N; Proietta M; Tritapepe L; Di Gioia C; Ferri L; Taurino M; Del Porto F
    Ann Med; 2015; 47(6):441-6. PubMed ID: 26339779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia.
    Karapanagiotidis GT; Antonitsis P; Charokopos N; Foroulis CN; Anastasiadis K; Rouska E; Argiriadou H; Rammos K; Papakonstantinou C
    J Cardiothorac Surg; 2009 Nov; 4():59. PubMed ID: 19886986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.
    Raffetto JD; Khalil RA
    Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases and acute aortic dissection: Et Tu, Brute?
    Takagi H; Hari Y; Nakashima K; Kuno T; Ando T
    Interact Cardiovasc Thorac Surg; 2020 Mar; 30(3):465-476. PubMed ID: 31808522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
    Kadoglou NP; Liapis CD
    Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prominent expression of plasma matrix metalloproteinase-8 in acute thoracic aortic dissection.
    Li Y; Shao AZ; Jiang HT; Dong GH; Xu B; Yi J; Jing H
    J Surg Res; 2010 Oct; 163(2):e99-104. PubMed ID: 20708200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms.
    Curci JA; Mao D; Bohner DG; Allen BT; Rubin BG; Reilly JM; Sicard GA; Thompson RW
    J Vasc Surg; 2000 Feb; 31(2):325-42. PubMed ID: 10664501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase were coupled with that of type I procollagen in granulation tissue response after the onset of aortic dissection.
    Akiyama M; Ohtani H; Sato E; Nagura H; Tabayashi K
    Virchows Arch; 2006 Jun; 448(6):811-21. PubMed ID: 16609908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling.
    Castro MM; Rizzi E; Prado CM; Rossi MA; Tanus-Santos JE; Gerlach RF
    Matrix Biol; 2010 Apr; 29(3):194-201. PubMed ID: 19969080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the matrix metalloproteinases during in vitro vessel formation.
    Burbridge MF; Cogé F; Galizzi JP; Boutin JA; West DC; Tucker GC
    Angiogenesis; 2002; 5(3):215-26. PubMed ID: 12831062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology.
    Lesauskaite V; Epistolato MC; Castagnini M; Urbonavicius S; Tanganelli P
    Hum Pathol; 2006 Aug; 37(8):1076-84. PubMed ID: 16867871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome.
    Ikonomidis JS; Jones JA; Barbour JR; Stroud RE; Clark LL; Kaplan BS; Zeeshan A; Bavaria JE; Gorman JH; Spinale FG; Gorman RC
    Circulation; 2006 Jul; 114(1 Suppl):I365-70. PubMed ID: 16820601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.
    Fondard O; Detaint D; Iung B; Choqueux C; Adle-Biassette H; Jarraya M; Hvass U; Couetil JP; Henin D; Michel JB; Vahanian A; Jacob MP
    Eur Heart J; 2005 Jul; 26(13):1333-41. PubMed ID: 15827062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKM2 Activator TEPP-46 Attenuates Thoracic Aortic Aneurysm and Dissection by Inhibiting NLRP3 Inflammasome-Mediated IL-1β Secretion.
    Le S; Zhang H; Huang X; Chen S; Wu J; Chen S; Ding X; Chen S; Zhao J; Xu H; Cui J; Zou Y; Yu J; Jiang L; Wu J; Ye P; Xia J
    J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):364-376. PubMed ID: 32323562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.